Clinical radioimmunotherapy of solid-tumors with chemically modified I-131 labeled chimeric TNT monoclonal antibodies.

被引：0
|
作者：
Jiang, C
Zhoang, G
Cesarman, G
Hu, P
Khawli, LA
Epstein, AL
机构：
[1] Shanghai Med Univ, Shanghai 200032, Peoples R China
[2] Natl Inst Nutr, Mexico City, DF, Mexico
[3] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1087
引用
收藏
页码：247P / 247P
页数：1
相关论文
共 50 条
  • [1] Radioimmunotherapy of glioblastoma by using I-131 and Y-90 labeled antitenascin Monoclonal Antibodies.
    Riva, P
    Franceschi, G
    Frattarelli, M
    Riva, N
    Guiducci
    Cremonini, AM
    Giuliani, G
    Casi, M
    Gentile, R
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH XXIII, 1999, : 59 - 63
  • [2] A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors
    Hornick, JL
    Sharifi, J
    Khawli, LA
    Hu, PS
    Biela, BH
    Mizokami, MM
    Yun, A
    Taylor, CR
    Epstein, AL
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (04) : 255 - 268
  • [3] Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen
    Qiu-jun LU~1
    Acta Pharmacologica Sinica, 2005, (10) : 1259 - 1264
  • [4] Radioimmunotherapy of carcinoma of colon with [131I]- labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen
    Qiu-jun Lu
    Guang-xing Bian
    Yuan-yuan Chen
    Min Zhang
    Shao-ming Guo
    Li-qing Wen
    Acta Pharmacologica Sinica, 2005, 26 : 1259 - 1264
  • [5] Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen
    Lu, QJ
    Bian, GX
    Chen, YY
    Zhang, M
    Guo, SM
    Wen, LQ
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (10) : 1259 - 1264
  • [6] INTRAPERITONEAL RADIOIMMUNOTHERAPY FOR OVARIAN-CANCER - RADIOPHARMACOKINETICS, TOXICITY AND EFFICACY OF I-131 LABELED MONOCLONAL-ANTIBODIES
    STEWART, JSW
    HIRD, V
    LAMBERT, HE
    EPENETOS, AA
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 519 - 519
  • [7] INTRAPERITONEAL RADIOIMMUNOTHERAPY FOR OVARIAN-CANCER - PHARMACOKINETICS, TOXICITY, AND EFFICACY OF I-131 LABELED MONOCLONAL-ANTIBODIES
    STEWART, JSW
    HIRD, V
    SNOOK, D
    SULLIVAN, M
    HOOKER, G
    COURTENAYLUCK, N
    SIVOLAPENKO, G
    GRIFFITHS, M
    MYERS, MJ
    LAMBERT, HE
    MUNRO, AJ
    EPENETOS, AA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (02): : 405 - 413
  • [8] EXPERIMENTAL RADIOIMMUNOTHERAPY OF HELA TUMORS IN NUDE-MICE WITH I-131-LABELED MONOCLONAL-ANTIBODIES
    RIKLUND, KE
    MAKIYA, RA
    SUNDSTROM, BE
    THORNELL, LE
    STIGBRAND, TI
    ANTICANCER RESEARCH, 1990, 10 (2A) : 379 - 384
  • [9] Phase I/II radioimmunotherapy with I-131 labeled chimeric monoclonal antibody cG250 in patients with metastasized renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oyen, WJG
    De Mulder, PHM
    Witjes, JA
    Oosterhof, GON
    Debruyne, FMJ
    Corstens, FHM
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 247P - 247P
  • [10] MINIMAL RESIDUAL DISEASE - A TARGET FOR RADIOIMMUNOTHERAPY WITH I-131 OR Y-90 LABELED MONOCLONAL-ANTIBODIES - SOME DOSIMETRIC CONSIDERATIONS
    HERBOLD, G
    SAUTTERBIHL, ML
    DORR, U
    BIHL, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 610 - 610
12345